Anti-A1 Lectin
- UID
- MFG/IVD/2021/000021_b5a3bdbceb0b3224f6a3ceeef48b61d8_a409c76f4e58b0bc28395be38bf113a5
- Device class
- Class D
- Brand name
- RPR
- License holder
- TULIP DIAGNOSTICS PRIVATE LIMITED
- Approving authority
- Sub Zonal Goa
- Product information
- Erybank Anti-A1 Lectin is a ready to use purified extract of Dolichos biflorus seeds to differentiate A1 red cells from A2 red cells
Anti-A1 Lectin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000021_b5a3bdbceb0b3224f6a3ceeef48b61d8_a409c76f4e58b0bc28395be38bf113a5. This device is marketed under the brand name RPR. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Goa.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.